Partners
We are constantly modernizing technological processes of our production
High-class pharmaceuticals
For 28 years we have been maintaining a persistently high level of quality and providing pharmacies with our products. The production capacity of the pharmaceutical company Medisorb is 2 billion 400 million tablets per year or 200 million per month, and this figure is growing annually. More than 15 million packages are shipped to pharmacies and institutions of medical and preventive treatment of Russia per month, which allows us to constantly uphold the reputation of a reliable manufacturer.
Learn moreManufacturing together
Our generics — your opportunities
We believe that the secret of our success at the market lies in long-term relationships with our partners due to stable product quality, timely response to inquiries, flexibility and, most importantly, openness and sincerity in business relations. Who do we consider to be our partner? Specialists dealing with procurement, supply of raw materials, products or any type of services and, on the whole, the company where they work. We consider you, a visitor of our official website, to be our partner as well. Find out how by means of our advantages we help to multiply yours. Learn moreYear in review
How we work
We can offer
Pharmaceutical development
Contract manufacturing, full production cycle and quality control
Distribution all over Russia
Regulatory & market access services
D-U-N-S® Registered™ |
The international cooperation
Cooperation of the pharmaceutical company Medisorb goes beyond the boundaries of the Russian Federation. We are constantly developing our contacts abroad, looking for new partners and increasing the level of collaboration with current ones. Today Medisorb produces medicines for 7 countries other than the Russian Federation. We ship our products to Armenia, Belarus, Georgia, Latvia, Moldova, Tajikistan and Uzbekistan. All our drugs, from generics to dietary supplements, are in demand among 15 purchasing companies. Especially interesting and promising product is the inhalation anesthetic «Sevoflurane Medisorb».